Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis

Journal of Medical Virology

Volumn 48, Issue 3, 1996, Pages 222-226

  Rösener, Martin ^a   Hahn, Heidi ^b   Kranz, Manuela ^b   Heeney, Jonathan ^c   Rethwilm, Axel ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

Amyotrophic lateral sclerosis; Human foamy virus; Motor neuron disease; Serology

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ARTICLE; CHIMPANZEE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MALE; MOTOR NEURON DISEASE; NONHUMAN; RETROVIRUS; SERODIAGNOSIS; SPUMA VIRUS; VIRUS INFECTION;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CRICETINAE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; PAN TROGLODYTES; RETROVIRIDAE INFECTIONS; SPUMAVIRUS;

ANIMALIA; HUMAN FOAMY VIRUS; HUMAN SPUMARETROVIRUS; PAN (APE); PAN TROGLODYTES; SPUMAVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0029975105     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199603)48:3<222::AID-JMV2>3.0.CO;2-A     Document Type: Article

References (45)

1. Achong BG, Epstein MA (1978): Preliminary seroepidemiological studies on the human syncytial virus. Journal of General Virology 40:175-181.
2. Achong BG, Mansell PWA, Epstein MA, Clifford P (1971): An unusual virus in cultures from a human nasopharyngeal carcinoma. Journal of the National Cancer Institute 46:299-307.
3. Aguzzi A, Wagner EF, Netzer KO, Bothe K, Anhauser I, Rethwilm A (1993): Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice. American Journal of Pathology 142:1061-1072.
4. Bothe K, Aguzzi A, Lassmann H, Rethwilm A, Horak I (1991): Progressive escephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science 253:555-557.
5. Brown P, Nemo G, Gajdusek DC (1978): Human foamy virus: Further characterization, seroepidemiology and relationship to chimpanzee foamy viruses. Journal of Infectious Diseases 137:421-427.
6. Chalmers AC, Greco CM, Miller RG (1991): Prognosis in AZT myopathy. Neurology 41:1181-1184.
7. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL (1990): Mitochondrial myopathy caused by long-term zidovudine therapy. New England Journal of Medicine 322:1098-1105.
8. Dorries R, Kaiser R, ter Meulen V (1989): Human immunodeficiency virus infection: Affinity-mediated immunoblot detects intrathecal synthesis of oligoclonal IgG specific for individual viral proteins. AIDS Research and Human Retroviruses 5:303-310.
9. Flügel RM (1993); The molecular biology of the human spumavirus. In Cullen BC (ed.): "Human Retroviruses - Frontiers in Molecular Biology." Oxford: Oxford University Press, pp 193-214.
10. Giron ML, Rozain F, Debons-Guillemin MC, CanivetM, Peries J, Emanoil-Ravier R (1993): Human foamy virus polypeptides: Identification of env and bel gene products. Journal of Virology 67:3596-3600.
11. Hahn H, Baunach G, Bräutigam S, Mergia A, Neumann-Haefelin D, Daniel MD, McClure MO, Rethwilm A (1994): Reactivity of primate sera to foamy virus gag and bet proteins. Journal of General Virology 75:2635-2644.
12. Herchenröder O, Renne R, Loncar D, Cobb EK, Murthy KK, Schneider J, Mergia A, Luciw PA (1994): Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): High homology to human foamy virus (HFV). Virology 201:187-199.
13. Hooks JJ, Gibbs CJ (1975): The foamy viruses. Bacteriological Reviews 39:169-185.
14. Iwasaki Y (1993): Human T cell leukemia virus type I infection and chronic myelopathy. Brain Pathology 3:1-10.
15. Johnston PB (1971): Taxonomie features of seven subtypes of simian and ape foamy viruses. Infection and Immunity 3:793-799.
16. Jubelt B (1992): Motor neuron diseases and viruses: Poliovirus, retroviruses, and lymphomas. Current Opinion in Neurology and Neurosurgery 5:655-658.
17. Kay DG, Gravel C, Pothier F, Laperrier A, Robitaille Y, Joliceur P (1993): Neurological disease induced in transgenic mice expressing the env gene of the Cas-Br-E murine retrovirus. Proceedings of the National Academy of Science (USA) 90:4538-4542.
18. Leigh PN, Ray-Chaundhuri K (1994): Motor neuron disease. Journal of Neurology, Neurosurgery, and Psychiatry 57:886-896.
19. Loh PC, Matsuura F, Mizumoto C (1980): Seroepidemiology of human syncytial virus: Antibody prevalence in the Pacific. Intervirology 13:87-90.
20. Mahnke C, Kashaiya P, Rössler J, Bannert H, Levin A, Blattner W, Dietrich. M, Luande J, Löchelt M, Friedman-Kien AE, Komaroff AL, Loh PC, Westarp ME, Flügel KM (1992): Human spumaretrovirus antibodies in sera from African patients. Archives of Virology 123:243-253.
21. Mhiri C, Baudrimont M, Bonne G, Geny C, Degoul F, Marsac C, Roullet E, Gherardi R (1991): Zidovudine myopathy: A distinctive disorder associated with mitochondrial dysfunction. Annals of Neurology 29:606-614.
22. Muller HK, Ball G, Epstein MA, Achong BG, Lenoir G, Levin A (1980): The prevalence of naturally occuring antibodies to human syncytial virus in East African populations. Journal of General Virology 47:399-406.
23. Nemo GJ, Brown PW, Gibbs CJ, Gajdusek DC (1978): Antigenic relationship of human foamy virus to the simian foamy viruses. Infection and Immunity 20:69-72.
24. Netzer KO, Rethwilm A, Maurer B, ter Meulen V (1990): Identification of the major immunogenic structural proteins of human foamy virus. Journal of General Virology 71:1237-1241.
25. Neumann-Haefelin D, Fleps U, Renne R, Schweizer M (1993): Foamy viruses. Intervirology 35:196-207.
26. Resnick L, DiMarzo-Veronese F, Schüppbach J, Tourtellotte WW, Ho DD, Müller F, Shapshak P, Vogt M, Groopman JE, Markham PD, Gallo RC (1985): Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. New England Journal of Medicine 313:1498-1504.
27. Rethwilm A (1995): Regulation of foamy virus gene expression. Current Topics in Microbiology and Immunology 193:1-24.
28. Rethwilm A, Darai G, Rösen A, Maurer B, Flügel RM (1987): Molecular cloning of the genome of human spumaretrovirus. Gene 59:19-28.
29. Rowland LP (1984): Looking for the cause of amyotrophic lateral sclerosis. New England Journal of Medicine 311:979-981.
30. Rowland LP (1991): Ten central themes in a decade of ALS research. Advances in Neurology 56:473-479.
31. Rowland LP (1994): Amyotrophic lateral sclerosis. Current Opinion in Neurology 7:310-315.
32. Rowland LP (1995): Amyotrophic lateral sclerosis: Human challenge for neuroscience. Proceedings of the National Academy of Science (USA) 92:1251-1253.
33. Schägger H, von Jagow G (1987): Tricine sodium dodecyl sulfate polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kD. Analytical Biochemistry 166: 368-379.
34. Schliephake AW, Rethwilm A (1994): Nuclear localization of foamy virus gag precursor protein. Journal of Virology 68:4946-4954.
35. Schweizer M, Neumann-Haefelin D (1995): Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. Virology 207:577-582.
36. Schweizer M, Turek R, Reinhardt M, Neumann-Haefelin D (1994): Absence of foamy virus DNA in Grave's disease. AIDS Research and Human Retroviruses 10:601-605.
37. Schweizer M, Turek R, Hahn H, Schliephake A, Netzer KO, Eder G, Reinhardt M, Rethwilm A, Neumann-Haefelin D (1995): Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: Appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Research and Human Retroviruses 11:161-170.
38. Sopper S, Hemm S, Meixensberger J, Coulibaly C, Stahl-Hennig C, Hunsmann G, Fleckenstein B, ter Meulen V, Dörries R (1993): Dynamics of the immune system response in cerebrospinal fluid and blood of SIVmac-infected rhesus monkeys. Journal of Medical Primatology 22:138-146.
39. Swash M, Leigh N (1992): Criteria for diagnosis of familial amytrophic lateral sclerosis. European FALS collaborative group. Neuromuscular Disorders 2:7-9.
40. Ukkonen P, Ganström ML, Räsänen J, Salonen EM, Penttinen K (1981): Local production of mumps IgG and IgM antibodies in the CSF of meningitis patients. Journal of Medical Virology 8:257-265.
41. Westarp ME, Kornhuber HH, Rössler J, Flügel RM (1992): Human spuma retrovirus antibodies in amytrophic lateral sclerosis. Neurology, Psychiatry and Brain Research 1:1-4.
42. Westarp ME, Westphal KP, Clausen J, Rasmussen HB, Hoff-Jorgensen R, Föhring B, Kornhuber HH (1993a): Retroviral interference with neuronotrophic signalling in human motor neuron disease. Clinical Physiology and Biochemistry 10:1-7.
43. Westarp ME, Bartmann P, Hoff-Jörgensen R, Clausen J, Rasmussen R, Kornhuber HH (1993b): Amyotrophe Lateralsklerose - Hinweise für eine erhöhte antiretrovirale Seroreaktivität ohne augenfällige Epidemiologie. Nervenarzt 64:384-389.
44. Westarp ME, Bartmann P, Rössler J, Geiger E, Westphal KP, Schreiber H, Fuchs D, Westarp MP, Kornhuber HH (1993c): Antiretroviral therapy in sporadic adult amyotrophic lateral sclerosis. NeuroReport 4:819-822.
45. Wigdahl B, Kunsch C (1989): Role of HIV in human nervous system dysfunction. AIDS Research and Human Retroviruses 5:369-374.